PYXIS ONCOLOGY INC. - COMMON STOCK
1.5800
10-January-25 09:30:01
15 minutes delayed
Stocks
-0.0300
-1.86%
Today's range
1.5800 - 1.5800
ISIN
N/A
Source
NASDAQ
-
Pyxis Oncology to Present at H.C. Wainwright Preclinical Cancer Drug Discovery Conference
28 Jun 2022 06:35:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Announces Presentations at Upcoming Investor Conferences
19 May 2022 06:35:00 By Nasdaq GlobeNewswire
-
13 May 2022 08:03:06 By Nasdaq GlobeNewswire
-
Pyxis Oncology to Participate in Fireside Chat at BofA Securities 2022 Healthcare Conference
27 Apr 2022 06:35:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Announces Leadership Changes
13 Apr 2022 06:35:00 By Nasdaq GlobeNewswire
-
08 Apr 2022 13:05:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Provides Corporate and Financial Update
29 Mar 2022 06:35:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology to Host Corporate Update Conference Call and Webcast on March 29, 2022
22 Mar 2022 06:35:00 By Nasdaq GlobeNewswire
-
Pyxis to be Added to Russell 2000® Index
15 Dec 2021 08:00:01 By Nasdaq GlobeNewswire
-
Pyxis Oncology Appoints Martina Molsbergen as Interim Chief Business Officer
09 Dec 2021 08:30:00 By Nasdaq GlobeNewswire
-
Pyxis Reports Financial Results for the Third Quarter of 2021 and Provides Business Update
15 Nov 2021 07:15:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology to Present at the Jefferies London Healthcare Conference
10 Nov 2021 08:00:02 By Nasdaq GlobeNewswire
-
Pyxis Announces Pricing of Upsized Initial Public Offering
07 Oct 2021 22:24:50 By Nasdaq GlobeNewswire